BioCentury
ARTICLE | Financial News

Affigen completes venture financing

February 24, 2017 2:20 AM UTC

On Feb. 21, cancer immunotherapy company Affigen Inc. (St. Louis, Mo.) raised $17 million in a series A round led by Black Beret Life Sciences....